Watchful waiting acceptable with provisos in AOM

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.483, 2005-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcomes of 200 Patients with Localized Prostate Cancer Enrolled in a Watchful Waiting Protocol

By Grimaldi J.P. Fleshner Neil DeBoer Gerrit Choo Richard Klotz Laurence

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 93-94

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Wait-and-see approach `feasible' in AOM

Inpharma, Vol. 1, Iss. 1275, 2001-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Single-dose azithromycin ER an attractive option for AOM

Inpharma, Vol. 1, Iss. 1558, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Costs of saxagliptin "acceptable" in Germany

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 648, 2012-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Business as usual is not acceptable

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 2864-2865

Blackwell Publishing

Access to resources Recommend Favorite